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Background: Chenopodium ambrosioides and Kielmeyera neglecta are plants traditionally used in Brazil to treat
various infectious diseases. The study of the biological activities of these plants is of great importance for the
detection of biologically active compounds.
Methods: Extracts from these plants were extracted with hexane (Hex), dichloromethane (DCM), ethyl acetate
(EtOAc) and ethanol (EtOH) and assessed for their antimicrobial properties, bioactivity against Artemia salina Leach
and antifungal action on the cell wall of Neurospora crassa.
Results: Extracts from C. ambrosioides (Hex, DCM and EtOH) and K. neglecta (EtOAc and EtOH) showed high
bioactivity against A. salina (LD50 < 1000 μg/mL), which might be associated with cytotoxic activity against cancer
cells. C. ambrosioides Hex and DCM showed specific activity against yeasts, highlighting the activity of hexanic
extract against Candida krusei (MIC = 100 μg/mL). By comparing the inhibitory concentration of 50% growth
(IC 50%) with the growth control, extracts from K. neglecta EtOAc and EtOH have shown activities against
multidrug-resistant bacteria (Enterococcus faecalis ATCC 51299 and Staphylococcus aureus ATCC 43300), with IC 50%
of 12.5 μg/mL The assay carried out on N. crassa allowed defining that extracts with antifungal activity do not have
action through inhibition of cell wall synthesis.
Conclusions: Generally speaking, extracts from C. ambrosioides and K. neglecta showed biological activities that
have made the search for bioactive substances in these plants more attractive, illustrating the success of their use
in the Brazilian folk medicine.
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The observed medical advances over the last years has led
to an increase in the survival of immunocompromised
people; because this population group is affected by some
disease that suppresses the immune system, such as AIDS,
or due to intensive use of chemotherapy or immunosup-
pressive drugs, these people are more susceptible to oppor-
tunistic infections like candidiasis, which are considered
difficult to treat in these cases [1-3]. In addition to this,* Correspondence: joaoluciano2002@yahoo.com.br
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reproduction in any medium, provided the orthere is an increase in the number of microorganisms re-
sistant or multiresistant to antibiotics [3-5], such as the
methicillin-resistant Staphylococcus aureus (MRSA), which
is one of the major bacterial species causing nosocomial
infections worldwide [6]. Together, these factors stimulate
the search for new drugs that are effective and less toxic to
patients [1,2,7]. In this context, natural products have been
historically and continue to be the focus of researches on
antimicrobial drugs [8], the main source of which is to be
found in plants [9].
The use of plants in the treatment of infectious diseases
is common since ancient times [10], evidencing its great
potential in the research of antimicrobial components.
This potential can be explained by the large variety and
complexity of secondary metabolites synthesized by plants
as a result of adaptive and defensive mechanisms againsttd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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are regarded as a great laboratory of organic synthesis, as
a result of millions of years of adaptation, providing an in-
valuable source of new molecules for researching anti-
microbial activities [12-14].
It is of great interest that experimental studies of new
drugs are conducted using ethnopharmacology, i.e., the
study of biological activities of plants with medicinal use
supported by popular knowledge [15], since this approach
has a great potential to find new bioactive substances [16].
Chenopodium ambrosioides Lineu is an herb of the Che-
nopodiaceae family, indigenous to South America, with
broad geographic distribution in Brazil, popularly known
as “mastruz” [17-19]; furthermore, this plant is traditionally
and widely used as anti-parasitic, anti-inflammatory and
antibiotic, which efficacy has been scientifically proven
[18,20,21]. The essential oil of C. ambrosioides is known to
inhibit the growth of yeast species [22], dermatophytes [23]
and other filamentous fungi [23,24] and the hexane extract
of C. ambrosioides is known to inhibit the growth of fila-
mentous fungi [17]. However, further studies are needed
with different microorganisms.
Kielmeyera neglecta Saddi is a plant of the Clusiaceae
family, endemical to Southern Bahia, Brazil, and found in
the Atlantic Forest [25]; this plant is popularly known as
“pau-santo” (holy-wood) [26], term also used to denomin-
ate plants of the same genus [27-29], which are used in the
Brazilian folk medicine to treat various infectious diseases
[4]. Previous studies have demonstrated the existence of
antibacterial and antifungal activities of extracts from these
plants [2,30], but additional studies are still needed.
Apart from dealing with the assessment of different
extracts from C. ambrosioides and K. neglecta as for their
antibacterial and antifungal properties, this study addresses
the bioactivity against Artemia salina Leach and the anti-
fungal effect on the cell wall of Neurospora crassa.
Methods
Plant material
Branches containing leaves and seeds of C. ambrosioides
were collected in Ilhéus, whereas leaves from K. neglecta
were collected in Una, both cities in the state of Bahia, Brazil.
Data collection was performed in May 2010; the material
was identified by the teacher Luiz Alberto Silva Mattos and
voucher specimens were deposited at the herbarium of Uni-
versidade Estadual de Santa Cruz (HUESC).
Preparation of extracts
After drying in a ventilated oven at 50°C, for 5 h, aerial
parts of C. ambrosioides (633.3 g) and leaves of K. neglecta
(1783.0 g) were ground and extracted by exhaustive ma-
ceration in sequence with the solvents hexane (Hex),
dichloromethane (DCM), ethyl acetate (EtOAc) and etha-
nol (EtOH); after filtration through filter paper, solventswere removed by a rotary evaporator, under reduced pres-
sure, and temperature below the boiling point of the solv-
ent, thus obtaining extracts Hex (15.2 g), DCM (18.6 g),
EtOAc (9.2 g) and EtOH (34.2 g) for C. ambrosioides and
Hex (28.3 g), DCM (47.7 g), EtOAc (16.4 g) and EtOH
(35.0 g) for K. neglecta. All extracts were kept in glass
flasks, at room temperature, until their application. For
the preparation of solutions to be used in the bioactivity
against Artemia salina, all extracts were solubilized in
ethanol so as to attain the desired concentration; regarding
the other assays, EtOAc and EtOH extracts were resus-
pended in dimethyl sulfoxide, whereas Hex and DCM
were resuspended in ethanol. The solutions for use in mi-
crobial assays were filtered through a 0.22 μm pore mem-
brane and maintained refrigerated until use.
Bacteria and fungi
The microorganisms used in the study were: Enterococcus
faecalis ATCC 29212, E. faecalis ATCC 51299, Escherichia
coli ATCC 25922, E. coli ATCC 35218, Klebsiella pneumo-
niae ATCC 700603, Pseudomonas aeruginosa ATCC 27853,
S. aureus ATCC 29213, S. aureus ATCC 43300, Candida
albicans ATCC 90028, C. albicans ATCC 10231, C. parapsi-
losis ATCC 90018, C. parapsilosis ATCC 22019, C. krusei
ATCC 6258. The N. crassa isolate used to assess antifungal
effects on the cell wall was kindly granted by Dr. Antonio
Carlos Monteiro (UNESP, Jaboticabal, Brazil).
Assay using Artemia salina
The assessment of bioactivity of extracts was carried out
following the methodology described by Meyer et al. [31],
with modifications. In order to obtain a nauplii population,
crustacean cysts (INVE do Brasil, Fortaleza, Brazil) were
incubated in sea water at room temperature, under direct
light, for 48 h. The preparation of solutions with different
concentrations of extract was performed by diluting the
working solution in sea water with 1% Tween 80. These
solutions were dispensed in 24-well plates to which ten
nauplii have been added, and plates were incubated at room
temperature, under direct light. After 6 and 24 h, the num-
ber of survivors was counted so as to determine the lethal
concentration capable of eliminating 50% of organisms
(LC50). The final concentrations of the tested extracts ran-
ged between 100 and 2000 μg/mL; the concentration of
Tween 80 was 0.94% and that of ethanol was below 1%.
Negative and positive controls were simultaneously per-
formed using the same concentrations of the working solv-
ent and K2Cr2O7 (0.33 mM), respectively. The assays were
performed in triplicate. LC50 was calculated using the
probit method (BioStat, 2009), with a 95% confidence
interval. The mortality was corrected using Abbott’s for-
mula: Mc ¼ Mt %ð Þ Mnc %ð Þ=100Mnc %ð Þ½   100 ,
where Mc= corrected mortality; Mt =mortality of the test;
Mnc=mortality of negative control [32].
Table 1 Bioactivity of extracts of Chenopodium
ambrosioides and Kielmeyera neglecta against Artemia
salina
LC50 (μg/mL)
Species Extract 6 h 24 h
K. neglecta Hex 2699.8 1050.8
DCM - * 1379.2
EtOAc 1324.8 780.8
EtOH 2154.5 977.7
C. ambrosioides Hex - # - #
DCM 1371.2 359.9
EtOAc - * 1444.4
EtOH 1059.0 356.6
Hex, hexane; DCM, dichloromethane; EtOAc, ethyl acetate; EtOH, ethanol. * No
deaths enough for statistical analysis; # High mortality, invalidating the
statistical test.
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Broth microdilution test was performed in accordance
with the norms established by the Clinical and Laboratory
Standards Institute (CLSI): M27-A6 [33], for bacteria, and
M27-A2 [34], for yeasts.
Bacterial (108 UFC/mL) and yeast cells (106 UFC/mL)
were inoculated in Mueller-Hinton broth and RPMI 1640
medium, respectively, in 96-well microdilution plates in
the presence of extract at different concentrations, with
final inoculum concentrations of 105 UFC/mL for bacteria,
and 103 UFC/mL for yeasts. After 24 h of incubation at
35°C, the minimum inhibitory concentration (MIC) -
considered the lowest concentration of the extract at which
there was no visible growth of organisms - and the inhibi-
tory concentration of 50% growth (IC 50%), defined as the
lowest concentration of extract that can inhibit 50% of vis-
ible microbial growth have been determined. In cases of
complete growth inhibition during the evaluation of anti-
fungal activity, the minimum fungicidal concentration
(MFC) defined as the lowest extract concentration that
could completely eliminate the microorganism was con-
firmed by re-inoculation of 20 μL of the medium in micro-
dilution culture plates in which there was no visible
growth in Sabouraud Dextrose Agar, and incubated for
48 h at 35°C. The final concentrations of the tested extracts
were 12.5-500 μg/mL for antibacterial activity, and 0.8-
500 μg/mL for antifungal activity. Controls on growth, ster-
ility of the medium, sterility of the extract, as well as nega-
tive (at the same concentrations of solvents) and positive
controls (chloramphenicol at 50 μg/mL and amphotericin
B at 5 μg/mL) were simultaneously conducted. All trials
were performed in triplicate.
Antifungal action on the cell wall of N. crassa
In the cell wall inhibition assay of N. crassa, the agar diffu-
sion method allows macroscopic detection of inhibitors of
fungal cell wall [35]. In appropriate medium and conditions
and in the presence of cell wall inhibitors, the fungus grows
as protoplasm, showing clear inhibition halo and undefined
borders [36]. Evaluation of the antifungal action of extracts
on the cell wall of N. crassa was performed following the
methodology proposed by Boeck et al. [35]. N. crassa was
grown on Sabouraud Dextrose Agar for 3 days, at room
temperature, directly exposed to sunlight, thus producing
an orange mycelium and spores; Using a Neubauer cham-
ber, the spore inoculum was prepared and adjusted to
1×106 spores/mL with a buffer solution containing
0.075 g/100 mL K2HPO4, 0.10 g/100 mL KH2PO4 in a
H2O 15:85 glycerol solution. Thirty milliliters of the os-
motic medium with 0.5% peptone, 1.0% yeast extract, 4.0%
sucrose and 1.5% agar has been autoclaved (121°C,
15 min). Shortly after, it was cooled to 45°C, 30 μL of the
spore inoculum were added, and the solution was homoge-
nized and placed in 90 mm diameter Petri plates; aftersolidification, 4.8 mm wells were made and 30 μL of solu-
tions from the testing extract were dispensed at a concen-
tration of 500 mg/mL achieved by diluting the working
solution in distilled water. After incubation at room
temperature, under direct light for 24 h, it has been macro-
scopically observed the presence of an inhibition halo. In
the presence of cell wall inhibitors, the fungus grows as
protoplasm, producing a halo of misty appearance. The
solvents used for dilution of the extract have been used as
a negative control, whereas ketoconazole (30 μg/mL) has
been used as a positive control. The assay consisted of
three separate trials.
Results and discussion
The crustacean A. salina is highly sensitive to a variety of
compounds [37] and is considered to be a useful screening
tool of active substances in bioassay [4,31]; furthermore, it
has good correlation with cytotoxicity in human cancer
cells [31,38]. As shown in Table 1, results indicate high bio-
activity (LC50 < 1000 μg/mL) for extracts from K. neglecta
EtOAc and EtOH, and C. ambrosioides DCM and EtOH
were considered as active [31,39,40]. As compared with the
other tested extracts, C. ambrosioides Hex showed very
high mortality rate (Figure 1) and thereby made it statisti-
cally impossible to calculate the LC50, but was considered
to be an active extract. Bioactivity in 6 h was only high for
C. ambrosioides Hex, reinforcing the possibility for this ex-
tract to contain bioactive compounds.
Antimicrobial activity was analyzed based on the results
of MIC and IC 50% displayed in Table 2. It was possible to
determine the minimal inhibitory concentration only for
the extract from C. ambrosioides Hex (100 μg/mL) against
C. krusei, which has clearly shown complete inhibition;
when examining the reading for 50% CI, the concentration
was 3.1 μg/mL. For some antifungals, the reading of MIC
is based on 50% of growth inhibition [34]; then, the
Figure 1 Mortality of Artemia salina to extracts of K. neglecta (KN) and C. ambrosioides (CA); Hex, hexane; DCM, dichloromethane;
EtOAc, ethyl acetate.
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plants with antimicrobial activity. An antimicrobial activity
can be considered as positive when the action of the extract
occurs at concentrations lower than 100 μg/mL [10]; hence,
when considering the reading of IC 50%, five extracts are
regarded as very important against at least one organism; on
the other hand, when analyzing MIC, only C. ambrosioides
Hex was considered significant. Despite the MIC and IC
50% at 100 μg/mL for C. ambrosioides Hex and DCM, re-
spectively, the genuine inhibitory concentration is between
that concentration read in the test and the one next lower
tested concentration [33]; then, its true 50% MIC/IC is lower
than 100 μg/mL. When analyzing the reading of IC 50%,
extracts from C. ambrosioides have not shown antibacterial
activity, but antifungal activity with Hex and DCM. In turn,Table 2 Antimicrobial activity of extracts of K. neglecta and C
Microorganisms K. neglecta
Hex DCM EtOAc
E. faecalis ATCC 29212 −/− −/− −/−
E. faecalis ATCC 51299 −/− −/− −/−
E. coli ATCC 25922 −/− −/− −/−
E. coli ATCC 35218 −/− −/− −/−
K. pneumoniae ATCC 700603 −/− −/− −/−
P. aeruginosa ATCC 27853 −/− −/− −/−
S. aureus ATCC 29213 -/12.5 −/− -/12.5
S. aureus ATCC 43300 −/− −/− -/12.5
C. albicans ATCC 90028 −/− −/− −/−
C. albicans ATCC 10231 −/− −/− −/−
C. parapsilosis ATCC 90018 −/− −/− -/300
C. parapsilosis ATCC 22019 −/− −/− -/300
C. krusei ATCC 6258 -/500 −/− -/200
Hex, hexane; DCM, dichloromethane; EtOAc, ethyl acetate; EtOH, ethanol. (−) No inh
50%, inhibitory concentration of 50% growth.K. neglecta showed antibacterial activity against Gram posi-
tive bacteria, as well as antifungal activity against non-
albicans Candida species (Hex, EtOAc, EtOH). It is note-
worthy that extracts from K. neglecta EtOAc and EtOH had
the same IC 50% when tested with E. faecalis ATCC 51299
and S. aureus ATCC 43300 multidrug-resistant bacteria.
As the extract from C. ambrosioides Hex was the only
one with complete inhibition of visible growth, the evalu-
ation of MFC was only performed for this extract. With a
final concentration of 200 μg/mL, this extract was consid-
ered to exert a fungicidal effect against C. krusei. This yeast
is regarded as intrinsically resistant to fluconazole and
resistant to other antifungals such as itraconazole and flucy-
tosine [41]; this is an interesting result because, as there is
an activity targeted against C. krusei, the compounds. ambrosioides
MIC/IC 50% (μg/mL)
C. ambrosioides
EtOH Hex DCM EtOAc EtOH
-/12.5 −/− −/− −/− −/−
-/12.5 −/− −/− −/− −/−
−/− −/− −/− −/− −/−
−/− −/− −/− −/− −/−
−/− −/− −/− −/− −/−
−/− −/− −/− −/− −/−
-/12.5 −/− −/− −/− −/−
-/12.5 −/− −/− −/− −/−
−/− −/− -/300 −/− −/−
−/− -/50 -/300 −/− −/−
−/− -/50 −/− −/− −/−
−/− -/50 -/300 −/− −/−
-/200 100/3.1 -/100 −/− −/−
ibition at the concentrations tested. MIC, minimum inhibitory concentration. IC
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drugs for an specific treatment of candidiasis caused by this
species, which has increased over the last years [41,42]. The
different concentrations of MIC (100 μg/mL) and MFC can
be explained by the reading of visible growth, without auto-
mation, as suggested by the CLSI [34]; that may result in
some variations in results.
The extracts that showed antimicrobial activity against
the tested yeasts, K.neglecta (Hex, EtOAc and EtOH) andFigure 2 Chemical structures identified from K. neglecta: friedelan-3-o
dihydroxy-6,6-dimethylpyrano(2,3;5,6)-40,40,50-trimethyldihydrofuran(2
of the author. (Oliveira, unpublished results).C. ambrosioides (Hex and DCM) were evaluated as for the
action on the cell wall of N. crassa, but showed no inhib-
ition halo at the tested concentration, either antifungal ac-
tion related to cell wall inhibition. Despite no action has
been detected on cell wall using this method, it is possible
that antifungal action occurs through another mechanism.
A preliminary chemical study of extracts of roots and
branches from K. neglecta resulted in the isolation of 24
substances which identification and determination ofne (A), friedelan-3-β-ol (B), β-sitosterol (C), stigmasterol (D), 1,8-
0,30;2,3)xanthone (E), 1,7-dihydroxyxanthone (F). With permission
Sousa et al. Annals of Clinical Microbiology and Antimicrobials 2012, 11:20 Page 6 of 7
http://www.ann-clinmicrob.com/content/11/1/20structures by spectrometric methods (UV, IR, ¹H NMR,
¹³C NMR, NOESY) and comparison with data from the lit-
erature were done. Isolated substances were the triterpenes
friedelan-3-one (friedelin) (Figure 2A) and friedelan-3-β-ol
(friedelinol) (Figure 2B); the steroids β-sitosterol (Figure 2C)
and stigmasterol (Figure 2D); and the xanthones 1,8-dihy-
droxy-6,6-dimethylpyrano(2,3;5,6)-40,40,50-trimethyldihydro-
furan(20,30;2,3)xanthone (Figure 2E) and 1,7-dihydroxyxanth-
one (Figure 2F) [43]. The analysis of biological activities with
the isolated compounds was not performed, but it might be
possible that the xanthones present in K. neglecta are syner-
gistically responsible for the antifungal activity presented in
this study, as some xanthones isolated from K. coriacea have
proven to have antifungal activity against Cladosporium
cucumerinum and C. albicans, whereof some have shown a
fungicidal effect against the latter [44]. Antimicrobial activity
against Candida species can also be explained by the com-
pound friedelin, which has been shown to have activity
against C. albicans, C. krusei and C. glabrata [45]. In
addition, friedelin has shown to have microbicidal activity
against E. faecalis [45] and S. aureus [46], whereas friedelinol
has shown to have microbicidal activity against S. aureus
[46].
A preliminary qualitative chemical analysis of extracts of
C. ambrosioides obtained in this study, conducted according
to Matos [47], revealed the presence of phenolic compounds,
tannins, flavonoids and steroids for the EtOH extract, phen-
olic compounds, tannins and flavonoids for the EtOAc
extract and flavonoids and steroids for the DCM extract.
Ascaridol has been the major antifungal compound identi-
fied in extracts of C. ambrosioides, with activity against
Aspergillus flavus, A. glaucus, A. ochraceous, A. niger, Fusar-
ium semitectum, F. oxysporum, Colletotrichum musae and
C. gloeosporioides. [17,24], being probably this compound
the responsible for the activity of C. ambrosioides against
Candida species in ours study.Conclusion
This study has demonstrated that these two plants - K.neglecta
and C. ambrosioides - used in the Brazilian folk medicine
are a potential source of substances with biological activ-
ities. By showing bioactivity against A. salina, K. neglecta
EtOAc and EtOH and C. ambrosioides Hex, DCM and
EtOH may be considered extracts that potentially contain
substances with cytotoxic activity against cancer cells. The
IC 50% determination has been proved to be useful in the
screening of extracts with antimicrobial activity and should
be considered as an important tool in researches involving
natural products. Extracts from K. neglecta EtOAc and
EtOH showed activity against multidrug-resistant bacteria,
which are of great concern in medicine nowadays; in turn,
C. ambrosioides Hex and DCM showed specific activity
against yeasts. These results showed here confirm oncemore the K. neglecta and C. ambrosioides extracts potential
biological activities.
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